We are utilizing modern molecular biological tools, such as microarray analysis and detailed studies of promoter regulation, to
unveil the genes and transcription factors regulating the decision of the beta cells to undergo apoptosis in early diabetes mellitus
and following islet transplantation.  Based on this information, we search for novel therapies for the disease.